Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Ousaiweike Biopharmaceutical Technology is a specialized biotechnology company dedicated to the development of advanced microneedle drug delivery systems. The company utilizes a proprietary dissolvable microneedle platform to facilitate the painless and efficient transdermal administration of various therapeutic agents, including proteins, peptides, and vaccines. By integrating micro-nanofabrication with pharmaceutical science, Ousaiweike aims to improve patient compliance and therapeutic outcomes while reducing the logistical burdens of cold-chain distribution. Their current development focus spans metabolic diseases, immunization, and aesthetic medicine, positioning them as a leader in the next generation of drug delivery technologies in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州欧赛微科生物医药科技.